Fassio, Angelo http://orcid.org/0000-0001-9187-232X
Andreola, Stefano
Gatti, Davide
Bianco, Beatrice
Gatti, Matteo
Gambaro, Giovanni
Rossini, Maurizio
Viapiana, Ombretta
Negrelli, Riccardo
Adami, Giovanni
Funding for this research was provided by:
Università degli Studi di Verona
Article History
Received: 22 August 2022
Accepted: 16 October 2022
First Online: 3 November 2022
Declarations
:
: DG has received advisory board honoraria, consultancy fees and/or speaker fees from Amgen, Celgene Eli-Lilly, MSD-Italia, Organon, UCB. MR has received advisory board honoraria, consultancy fees and/or speaker fees from Abiogen, Amgen, Abbvie, BMS, Celgene, Eli-Lilly, Galapagos, Grunenthal, MSD, Novartis, Pfizer, Sanofi, Sandoz, Theramex, UCB. GG has received speaker and advisory board honoraria from Vifor Pharma. All other Authors declare no conflict of interests.
: The study was conducted within the protocol 1483CESC approved by our local Ethics Committee, in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Written informed consent was obtained from all participants included.